| | | | | | | | | | |
|
| |
|
| Dockets Entered
On October 15, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1981N-0033
|
| Oral Health Care Drug Products for OTC Human Use
|
|
|
|
|
| 1987C-0023
|
| SAFE USE OF CARBON BLACK FOR COLORING COSMETICS
|
|
|
|
|
| 1996P-0418
|
| Reduce the Precense of Salmonella Enteritidis in Shell Eggs
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003P-0064
|
| Withhold Approval of Generic Lovenox (enoxaparin sodium inje
|
|
|
|
|
| 2004N-0081
|
| BSE Risk Materials in Foods and Cosmetics
|
|
|
|
|
| 2004N-0115
|
| Prescription Drug Importation Study
|
|
|
|
|
| 2004N-0242
|
| Institutional Review Boards; Registration Requirements
|
|
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
|
|
| 2004N-0267
|
| Applications for Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications
|
|
|
|
|
| 2004N-0289
|
| Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter
|
|
|
|
|
| 2004N-0441
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Application For FDA Approval to Market a New Drug
|
|
|
|
|
| 2004P-0202
|
| Notify State & Federal regulators of GRAS requirements of milk protein Concentrate
|
|
|
|
|
| 2004P-0349
|
| Action on Products containing added Mercury
|
|
|
|
|
| 2004P-0411
|
| Compel Enforcement and Regulation of Amyl Nitrate
|
|
| |
|
| 1981N-0033
|
| Oral Health Care Drug Products for OTC Human Use
|
|
|
|
|
| C
75
|
| Olsson, Frank and Weeda, P.C.
|
| Vol #:
|
| 72
|
|
|
|
|
| 1987C-0023
|
| SAFE USE OF CARBON BLACK FOR COLORING COSMETICS
|
|
|
|
|
| NFR
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 1996P-0418
|
| Reduce the Precense of Salmonella Enteritidis in Shell Eggs
|
|
|
|
|
| C 831
|
| T. Duong
|
| Vol #:
|
| 33
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| EMC 10594
|
| B. Townsend
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10595
|
| K. Quinlan
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10596
|
| V. Frack
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10597
|
| J. Rastegar
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10598
|
| P. Pierce
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10599
|
| A. Boothby
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10600
|
| C. Fernquist
|
| Vol #:
|
| 294
|
|
|
|
|
| EMC 10601
|
| M. Lines
|
| Vol #:
|
| 294
|
|
| | | | | | | | |
|
| |
|
| EMC 1106
|
| D. LeClair
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1107
|
| S. Mahon
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1108
|
| Animal Welfare Trust (AWT)
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1109
|
| People for the Ethical Treatment of Animals (PETA)
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1110
|
| J. Embry
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1111
|
| D. Crossmon
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1112
|
| Devro, Inc.
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1113
|
| Argentina
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1114
|
| Nitta Casings, Inc.
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1115
|
| American Assn of Meat Processors (AAMP)
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1116
|
| L. Grayson, RN
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1117
|
| American Assn of Meat Processors (AAMP)
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1118
|
| L. Silverman
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1119
|
| Humane Society of the United States (HSUS)
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1120
|
| N and G Shinn
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1121
Attachment
|
| Gelatin Manufacturers Assn of Japan
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC
1122
Attachment
|
| Gelatin Manufacturers Assn of Japan
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 1123
|
| B. Ross
|
| Vol #:
|
| 11
|
|
| |
|
| 2004N-0115
|
| Prescription Drug Importation Study
|
|
|
|
|
| EMC
23
|
| Secure Symbology, Inc.
|
| Vol #:
|
| 19
|
|
|
|
|
| 2004N-0242
|
| Institutional Review Boards; Registration Requirements
|
|
|
|
|
| C
7
|
| University of California
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0264
|
| Federal Measures to Mitigate BSE Risks: Considerations for Further Action
|
|
|
|
|
| C
190
|
| G.A.O.B., Inc.
|
| Vol #:
|
| 23
|
|
|
|
|
| C 191
|
| A. Taylor
|
| Vol #:
|
| 23
|
|
|
|
|
| EMC 1429
|
| R. Leder, DVM
|
| Vol #:
|
| 19
|
|
|
|
|
| 2004N-0267
|
| Applications for Approval to Market a New Drug; Complete Response Letter; Amendments to Unapproved Applications
|
|
|
|
|
| C
1
|
| AstraZeneca
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC
1
|
| Apotex, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0289
|
| Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter
|
|
|
| C 2
|
| A. Bell
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0441
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Application For FDA Approval to Market a New Drug
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
